09/19/2014 | Reply brief filed | Petitioner | Reply brief on the Merits filed on behalf of Randoll Mill Pharmacy, et al. |
| |||
09/05/2014 | Brief filed | Respondent | Brief on the Merits filed on behalf of Stacey and Randy Miller. |
|
FDA
will be able to collect new drug compounding user fees authorized by
the Drug Quality and Security Act (DQSA) under the continuing resolution
that cleared Congress and was signed by President Barack Obama last
week.